Ivan P. Gergel, SVP & Chief Medical Officer at NEKTAR THERAPEUTICS (NKTR), sold 43,296 shares at $24.04 ($1.0M) on 2017-09-29, disclosed to the SEC on 2017-10-03.
Open-market sale of $1.0M NKTR by SVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2017-08-18 | $39K | — | Filing → |
| NKTR | SELL | 2017-07-20 | $1.2M | — | Filing → |
| NKTR | SELL | 2017-07-13 | $1.9M | — | Filing → |